JP2006528215A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528215A5
JP2006528215A5 JP2006529752A JP2006529752A JP2006528215A5 JP 2006528215 A5 JP2006528215 A5 JP 2006528215A5 JP 2006529752 A JP2006529752 A JP 2006529752A JP 2006529752 A JP2006529752 A JP 2006529752A JP 2006528215 A5 JP2006528215 A5 JP 2006528215A5
Authority
JP
Japan
Prior art keywords
formula
compound
reacted
give
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006529752A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528215A (ja
JP4408291B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/004843 external-priority patent/WO2004101558A1/en
Publication of JP2006528215A publication Critical patent/JP2006528215A/ja
Publication of JP2006528215A5 publication Critical patent/JP2006528215A5/ja
Application granted granted Critical
Publication of JP4408291B2 publication Critical patent/JP4408291B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006529752A 2003-05-13 2004-05-06 アデノシン受容体リガンドとしての2−イミダゾ−ベンゾチアゾール Expired - Fee Related JP4408291B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03009842 2003-05-13
PCT/EP2004/004843 WO2004101558A1 (en) 2003-05-13 2004-05-06 2-imidazo-benzothiazoles as adenosine receptor ligands

Publications (3)

Publication Number Publication Date
JP2006528215A JP2006528215A (ja) 2006-12-14
JP2006528215A5 true JP2006528215A5 (https=) 2009-11-26
JP4408291B2 JP4408291B2 (ja) 2010-02-03

Family

ID=33395778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006529752A Expired - Fee Related JP4408291B2 (ja) 2003-05-13 2004-05-06 アデノシン受容体リガンドとしての2−イミダゾ−ベンゾチアゾール

Country Status (15)

Country Link
US (1) US7122545B2 (https=)
EP (1) EP1636217B1 (https=)
JP (1) JP4408291B2 (https=)
KR (1) KR100710453B1 (https=)
CN (1) CN100372844C (https=)
AT (1) ATE407133T1 (https=)
AU (1) AU2004238508B2 (https=)
BR (1) BRPI0410315A (https=)
CA (1) CA2523959A1 (https=)
DE (1) DE602004016328D1 (https=)
ES (1) ES2313001T3 (https=)
MX (1) MXPA05012120A (https=)
PL (1) PL1636217T3 (https=)
RU (1) RU2340612C2 (https=)
WO (1) WO2004101558A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1910385B1 (en) * 2005-08-04 2013-07-24 Sirtris Pharmaceuticals, Inc. Benzothiazoles and thiazolopyridines as sirtuin modulators
TW200736252A (en) 2006-01-27 2007-10-01 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
TW200813035A (en) 2006-06-19 2008-03-16 Astrazeneca Ab Novel heteroaryl substituted benzoxazoles
TW200901998A (en) 2007-03-06 2009-01-16 Astrazeneca Ab Novel 2-heteroaryl substituted benzothiophenes and benzofuranes
WO2010115736A2 (en) * 2009-04-02 2010-10-14 Merck Serono S.A. Dihydroorotate dehydrogenase inhibitors
EP2414340A1 (en) * 2009-04-03 2012-02-08 Dainippon Sumitomo Pharma Co., Ltd. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
US8575336B2 (en) 2011-07-27 2013-11-05 Pfizer Limited Indazoles
WO2016164565A1 (en) * 2015-04-08 2016-10-13 University Of Delaware Trans-cycloheptenes and hetero-trans-cycloheptenes for bioorthogonal coupling
WO2018193090A2 (en) * 2017-04-21 2018-10-25 Amneal Pharmaceuticals Company Gmbh Process for preparation of eliglustat hemitartrate and intermediates thereof
AU2018320673B2 (en) 2017-08-21 2023-03-30 Merck Patent Gmbh Benzimidazole derivatives as adenosine receptor antagonists
WO2025160629A1 (en) * 2024-01-31 2025-08-07 Certa Therapeutics Pty Ltd Proton sensing gpcr modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI91859C (fi) * 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
IT1260444B (it) * 1992-01-24 1996-04-09 Mario Brufani Derivati della 8-(1-amminocicloalchil)1,3-dialchilxantina, procedimenbto di preparazione e loro composizioni farmaceutiche antidepressive, nootropiche e psicostimolanti
US6037473A (en) * 1997-11-13 2000-03-14 Haarmann & Reimer Gmbh Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation
US6841549B1 (en) * 1999-07-02 2005-01-11 Eisai Co., Ltd. Condensed imidazole compounds and a therapeutic agent for diabetes mellitus
AU8181701A (en) * 2000-06-21 2002-01-02 Hoffmann La Roche Benzothiazole derivatives
PL1628662T3 (pl) * 2003-05-21 2007-07-31 Hoffmann La Roche Pochodne benzotiazolu i ich zastosowanie w leczeniu chorób związanych z receptorem adenozynowym A2A

Similar Documents

Publication Publication Date Title
JP2010510976A5 (https=)
JP2006528215A5 (https=)
JP2018529687A5 (https=)
CN1305471A (zh) 二氢嘧啶类化合物
RU2009110413A (ru) Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты
JP2012521411A5 (https=)
JP2010513494A5 (https=)
JP2010531876A5 (https=)
JP2005507873A5 (https=)
JP2006519818A5 (https=)
JP2005525427A5 (https=)
JP2007520453A5 (https=)
CN1582272A (zh) 制备5-(3-氰基苯基)-3-甲酰基苯甲酸化合物的方法
JP2019214626A5 (https=)
JP2005502603A5 (https=)
JP2010511047A5 (https=)
CN1922193B (zh) 化学方法
CN1036712C (zh) 抗病毒剂[1R-(1α,2β,3α)]-2-氨基-9-[2,3-双(羟甲基)环丁基]-1,9-二氢-6H-嘌呤-6-酮的制备方法
JP2018505179A5 (https=)
JP2004137258A5 (https=)
JP2011506323A5 (https=)
JP4422183B2 (ja) ジイソプロピル((1−(ヒドロキシメチル)−シクロプロピル)オキシ)メチルホスホネートの製造方法
JP4239462B2 (ja) ピリドン化合物の製造法およびその中間体
JP2004018389A5 (https=)
JP2006160643A5 (https=)